The DEA Rescheduling Hearing Is Over. States Should Lead Cannabis Research
State-led cannabis research infrastructure: The DEA rescheduling hearing concluded in July 2026, marking a procedural milestone. Experts argue that the clinical benefits of rescheduling depend on states building dedicated cannabis research…
THC-Dominant Edibles and Chronic Low Back Pain: What a New Real-World Study Found
Thc dominant edible cannabis chronic low back pain: This study examines THC dominant edible cannabis and its association with lower daily pain intensity in adults with chronic low back pain. Findings suggest THC dominant products correlate with reduced…
Cannabinoids and Cognitive Function in Bipolar Disorder: What a New Study Found
A new study on cannabinoids cognition bipolar disorder examined whether cannabis use correlates with improved timing and attention in people with bipolar disorder. Chronic cannabis users performed similarly to healthy adults, and an acute THC challenge…
CED Cannabis Science Digest: CHS Blood Profiles, CB2 Analgesia, and the Gut-Brain Axis
CHS blood profiles did not differ significantly from acute cannabis intoxication in a small emergency-department study. Two additional papers explore preclinical CB2 analgesia and mechanistic gut-brain pathways. None establishes a diagnostic blood test…
What a New Study Reveals About Cannabis and Inguinal Hernia Repair Outcomes
A recent study on cannabis exposure and outcomes after inguinal hernia repair found no significant increase in early wound complications. However, it identified a higher long-term recurrence rate after open repair in cannabis users. These findings…
Medical Cannabis Beyond Pain: PM&R Review on Spasticity, Seizures, Sleep & Nausea
A PM&R-focused narrative review examines medical cannabis non-pain indications including spasticity, seizures, sleep disturbances, and chemotherapy-induced nausea. While patient-reported symptom benefits are noted, evidence for functional outcome…
CBD Versus Codeine After Laser Eye Surgery: What a 35-Person Trial Found
A 35-person randomized crossover trial compared oral CBD versus codeine after laser eye surgery, finding no significant difference in pain scores. Recovery outcomes were similar, though mild sensorium changes occurred with initial CBD use. This trial…
What Happens After Cannabis Laws Change? A Review of 176 Policy Studies
Cannabis policy and substance use evidence from 176 quasi-experimental reports shows adult cannabis use often rises after liberalization. Alcohol, tobacco, opioid, and youth outcomes varied by policy and population. The review supports targeted…
Purified CBD and Epilepsy: Insights on Nonseizure Outcomes from New Review
A recent systematic review examined highly purified cannabidiol epilepsy treatment focusing on nonseizure outcomes such as cognition, behavior, and quality of life. The evidence, mainly observational, suggests potential benefits but remains inconclusive…
Daily Cannabis Use Surpasses Cigarettes and Alcohol: Trend Data Explained
Cannabis-only use trends 2025 reveal a significant shift as daily cannabis use surpasses cigarette and alcohol use among US adults. This peer-reviewed data highlights important considerations for clinical screening and counseling in cannabis medicine.…